Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: A post hoc analysis of data from severely ill patients

Clinical Therapeutics

Volumn 28, Issue 8, 2006, Pages 1175-1180

  Grossman, Ronald F ^a   Ambrusz, Mary E ^b   Fisher, Alan C ^b   Khashab, Mohammed M ^b   Kahn, James B ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

acute bacterial exacerbation of chronic bronchitis; amoxicillin clavulanate; levofloxacin; short course; tolerability

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; LEVOFLOXACIN;

ABDOMINAL PAIN; ADULT; AGED; AIRWAY OBSTRUCTION; ANEMIA; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BONE PAIN; BRONCHITIS; CHOLELITHIASIS; CHRONIC BRONCHITIS; CLINICAL TRIAL; COMORBIDITY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DRUG INDICATION; DRUG TOLERABILITY; DYSPEPSIA; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL HEMORRHAGE; GENITAL CANDIDIASIS; GRAM NEGATIVE BACTERIUM; HEART FAILURE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NAUSEA; NONHUMAN; PNEUMONIA; PNEUMOTHORAX; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; RHINITIS; SARCOIDOSIS; SINUSITIS; SMOKING; SPUTUM; SYMPTOMATOLOGY; TACHYCARDIA; THROMBOPHLEBITIS; TREATMENT OUTCOME; VEIN DISEASE;

AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BRONCHITIS; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; OFLOXACIN;

EID: 33748686047     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2006.08.013     Document Type: Article

References (22)

1. Anthonisen N.R., Manfreda J., Warren C.P., et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106 (1987) 196-204
2. Adams S.G., Melo J., Luther M., and Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest 117 (2000) 1345-1352
3. Balter M.S., La Forge J., Low D.E., et al., Canadian Thoracic Society and the Canadian Infectious Disease Society. Canadian guidelines for the management of acute exacerbations of chronic bronchitis. Can Respir J 10 Suppl B (2003) 3B-32B
4. Grossman R.F. Guidelines for the treatment of acute exacerbations of chronic bronchitis. Chest 112 (1997) 310S-313S
5. Miravitlles M., Murio C., Guerrero T., and DAFNE Study Group. Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. Eur Respir J 17 (2001) 928-933
6. Dewan N.A., Rafique S., Kanwar B., et al. Acute exacerbation of COPD: Factors associated with poor treatment outcome. Chest 117 (2000) 662-671
7. Soler N., Torres A., Ewig S., et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 157 (1998) 1498-1505
8. Miravitlles M., Espinosa C., Fernandez-Laso E., et al., Study Group of Bacterial Infection in COPD. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest 116 (1999) 40-46
9. Eller J., Ede A., Schaberg T., et al. Infective exacerbations of chronic bronchitis: Relation between bacteriologic etiology and lung function. Chest 113 (1998) 1542-1548
10. Obaji A., and Sethi S. Acute exacerbations of chronic bronchitis. What role for the new flouroquinolones?. Drugs Aging 18 (2001) 1-11
11. Martinez F.J., Grossman R.F., Zadeikis N., et al. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: The role of levofloxacin 750 mg. Eur Respir J 25 (2005) 1001-1010
12. [WMA Web site]. World Medical Association Declaration of Helsinki. Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects. Accessed August 3, 2006 (1989), WMA, Ferney-Voltaire, France. http://www.wma.net/e/ethicsunit/helsinki.htm Accessed August 3, 2006
13. [EMEA Web site]. European Agency for the Evaluation of Medicinal Products. Accessed August 3, 2006. International Conference on Harmonisation World Health Organization. Guideline for Good Clinical Practice. ICH Topic E6 (2002), WHO, Geneva, Switzerland. http://www.emea.eu.int/Inspections/GCPgeneral.html Accessed August 3, 2006
14. Document M100-S15. Clinical and Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing; fifteenth informational supplement (2005), Clinical and Laboratory Standards Institute, Wayne, Pa
15. Approved Standard-Seventh Edition. Document M7-A7. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically (2005), Clinical and Laboratory Standards Institute, Wayne, Pa
16. Martinez F.J. Acute bronchitis: State of the art diagnosis and therapy. Comp Ther 30 (2004) 55-69
17. Martinez F.J. Acute exacerbations of chronic bronchitis: Diagnosis and therapy. JCOM 11 (2004) 659-673
18. Wilkinson T.M., Donaldson G.C., Hurst J.R., et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1298-1303
19. Donaldson G.C., Seemungal T.A., Bhowmik A., and Wedzicha J.A. Relationship between exacerbation frequen cy and lung function decline in chronic obstructive pulmonary disease. Thorax 57 (2002) 847-852
20. Miravidles M., Ferrer M., Pont A., et al., IMPAC Study Group. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: A 2 year follow up study. Thorax 59 (2004) 387-395
21. Wilson R., Schentag J.J., Ball P., Mandell L., and 068 Study Group. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and longterm clinical outcomes. Clin Ther 24 (2002) 639-652
22. Wilson R., Allegra L., Huchon G., et al. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 125 (2004) 953-964